ClinicalTrials.gov
ClinicalTrials.gov Menu

Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00357669
Recruitment Status : Completed
First Posted : July 27, 2006
Last Update Posted : May 18, 2015
Sponsor:
Information provided by (Responsible Party):
UCB Pharma ( UCB Pharma SA )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2007
  Actual Study Completion Date : October 2007